Dr. Martyn Bullock started his scientific career in Wales, where he completed his PhD investigating the role FOXE1 plays in thyroid gland development under the supervision of Prof. Marian Ludgate at Cardiff University. After graduating, Martyn moved to Australia to undertake his postdoctoral work in the laboratory of Prof. Roderick Clifton-Bligh and Prof. Bruce Robinson at the Kolling Institute, University of Sydney, where he studied transcriptional regulation of the TERT gene in thyroid cancer. He has several first author publications in journals like Thyroid and JCEM and has received multiple awards, grants and fellowships, including a Young Investigator Award from the Asia & Oceania Thyroid Association. Currently, he leads three major research topics: (1) Elucidating developmental transcriptional networks that are hijacked in thyroid tumor development, (2) Drug discovery aimed to identify drugs that exhibit potent inhibitory activity upon the mutated TERT promoter in thyroid cancer cells, and (3) Utilizing circulating tumour DNA to determine effectiveness of targeted therapies in cancer.